Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

8 results
Display

Comparative Analysis of the Three Classes of Archaeal and Bacterial Ribonucleotide Reductase from Evolutionary Perspective

Pangare MG, Chandra SB

  • KMID: 1806199
  • Genomics Inform.
  • 2010 Dec;8(4):170-176.
The Ribonucleotide reductases (RNR) are essential enzymes that catalyze the conversion of nucleotides to deoxynucleotides in DNA replication and repair in all living organisms. The RNRs operate by a free...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Functions of Herpesvirus-Encoded Homologs of the Cellular Ribonucleotide Reductase Large Subunit

Kwon KM, Ahn JH

Deoxyribonucleotides (dNTPs) are important for the efficient growth of DNA viruses. Therefore, many DNA viruses have strategies for the upregulation of cellular dNTP levels. Both α- and γ-herpesviruses encode functional...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hydroxyurea Therapy in Hemoglobin Madrid Patients

Seo YK, Lee EH, Kim TW, Yang JH, Jung HL, Shim JY, Park MS, Keum DH

  • KMID: 2252435
  • Korean J Hematol.
  • 2002 Feb;37(1):54-59.
Unstable hemoglobins (Hb) are variants of adult Hb that tend to precipitate and form insoluble inclusions (Heinz bodies) within red blood cells (RBC) and RBC precursors. More than 100 structurally...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Hydroxyurea-Induced Cutaneous Ulceration and Squamous Cell Carcinoma

Yun SJ, Lee JB, Kim SJ, Lee SC, Won YH

  • KMID: 1604675
  • Korean J Dermatol.
  • 2002 Apr;40(4):433-436.
Hydroxyurea, one of conventional chemotherapies in chronic myelogenous leukemia(CML) and polycythemia vera, inhibits ribonucleotide reductase, which catalyzes the rate-limiting step in the de novo synthesis of deoxynucleotide triphosphates required for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Long-Term Follow-Up Result of Hydroxyurea Chemotherapy for Recurrent Meningiomas

Kim MS, Yu DW, Jung YJ, Kim SW, Chang CH, Kim OL

OBJECTIVE: Meningiomas represent 18-20% of all intracranial tumors and have a 20-50% 10-year recurrence rate, despite aggressive surgery and irradiation. Hydroxyurea, an inhibitor of ribonucleotide reductase, is known to inhibit...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Promoter Polymorphism of RRM1 Gene in Korean Lung Cancer Population

Ko KH, Kim EJ, Oh IJ, Kim SO, Son JG, Jung JP, Cho GJ, Ju JY, Kim KS, Kim YI, Lim SC, Kim YC, Bepler G

BACKGROUND: LOH11A is a region with frequent allele loss (>75%) in lung cancer that is located on the centromeric part of chromosome 11p15.5. Clinical and cell biological studies suggest that...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Combination of Mutated Herpes Simplex Virus (G207) with Radiation for the Treatment of Squamous Cell Carcinoma of the Head and Neck

Kim SH, Choi EC, Han DH, Han SJ, Kim JH, Nam JI, Kim KM

  • KMID: 2276000
  • Korean J Otolaryngol-Head Neck Surg.
  • 2003 Feb;46(2):139-146.
BACKGROUND AND OBJECTIVES: G207 virus is an ideal candidate of oncolytic viral therapy. It is a multi-gene mutant of HSV-1 with a deletion at the gamma34.5 loci and a LacZ...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Gemcitabine Therapy in Patients with Advanced Pancreatic Cancer

Min YJ, Joo KR, Park NH, Yun TK, Nah YW, Nam CW, Park JH

  • KMID: 759621
  • Korean J Intern Med.
  • 2002 Dec;17(4):259-262.
BACKGROUND: Advanced, unresectable pancreatic cancer is an extremely aggressive disease. The 5-year survival rate for pancreatic cancer is only less than 5%. Current therapeutic options for patients with locally...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr